Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: Evidence of homozygous deletion in a noninvasive precursor lesion

Steven R. Hustinx, Lorenzo M. Leoni, Charles J. Yeo, Priscilla N. Brown, Michael S Goggins, Scott E Kern, Ralph H Hruban, Anirban Maitra

Research output: Contribution to journalArticle

Abstract

The p16INK4A/CDKN2A (p16) gene on chromosome 9p21 is inactivated in >90% of invasive pancreatic cancers. In 40% of pancreatic cancers the p16 gene is inactivated by homozygous deletion, in 40% by an intragenic mutation coupled with loss of the second allele, and in 10-15% by hypermethylation of the p16 gene promoter. Immunohistochemical labeling for the p16 gene product parallels gene status, but does not provide information of the mechanism of p16 gene inactivation. The methylthioadenosine phosphorylase gene (MTAP) gene also resides on chromosome 9p21, approximately 100kb telomeric to the p16 gene. The MTAP gene is frequently contained within p16 homozygous deletions, producing concordant loss of both p16 and MTAP gene expression. Concordant loss of both p16 and MTAP protein expression can therefore be used as a surrogate marker for p16 homozygous deletion. Here we immunolabeled a series of pancreatic intraepithelial neoplasia (PanIN) lesions of various histologic grades for the p16 and MTAP gene products using a high-throughput PanIN tissue microarray (TMA) format. We demonstrate concordant loss of p16 and MTAP protein expression in 6/73 (8%) PanINs, including five high-grade lesions and one low-grade lesion. Immunolabeling for both p16 and MTAP protein expression provides a tool to evaluate tissues with intact morphology for p16 gene homozygous deletions. The concordant loss of expression of both genes in PanIN lesions demonstrates that homozygous deletions of the p16 tumor suppressor gene can occur in noninvasive precursor lesions.

Original languageEnglish (US)
Pages (from-to)959-963
Number of pages5
JournalModern Pathology
Volume18
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

p16 Genes
Neoplasms
Genes
Gene Expression
5'-methylthioadenosine phosphorylase
Pancreatic Neoplasms
Chromosomes
Proteins
Gene Deletion
Gene Silencing
Tumor Suppressor Genes

Keywords

  • Homozygous deletion
  • MTAP
  • p16
  • Pancreatic intraepithelial neoplasia
  • Precursor lesion

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia : Evidence of homozygous deletion in a noninvasive precursor lesion. / Hustinx, Steven R.; Leoni, Lorenzo M.; Yeo, Charles J.; Brown, Priscilla N.; Goggins, Michael S; Kern, Scott E; Hruban, Ralph H; Maitra, Anirban.

In: Modern Pathology, Vol. 18, No. 7, 07.2005, p. 959-963.

Research output: Contribution to journalArticle

@article{165f300e1e114c6b98fde95e6dba187e,
title = "Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: Evidence of homozygous deletion in a noninvasive precursor lesion",
abstract = "The p16INK4A/CDKN2A (p16) gene on chromosome 9p21 is inactivated in >90{\%} of invasive pancreatic cancers. In 40{\%} of pancreatic cancers the p16 gene is inactivated by homozygous deletion, in 40{\%} by an intragenic mutation coupled with loss of the second allele, and in 10-15{\%} by hypermethylation of the p16 gene promoter. Immunohistochemical labeling for the p16 gene product parallels gene status, but does not provide information of the mechanism of p16 gene inactivation. The methylthioadenosine phosphorylase gene (MTAP) gene also resides on chromosome 9p21, approximately 100kb telomeric to the p16 gene. The MTAP gene is frequently contained within p16 homozygous deletions, producing concordant loss of both p16 and MTAP gene expression. Concordant loss of both p16 and MTAP protein expression can therefore be used as a surrogate marker for p16 homozygous deletion. Here we immunolabeled a series of pancreatic intraepithelial neoplasia (PanIN) lesions of various histologic grades for the p16 and MTAP gene products using a high-throughput PanIN tissue microarray (TMA) format. We demonstrate concordant loss of p16 and MTAP protein expression in 6/73 (8{\%}) PanINs, including five high-grade lesions and one low-grade lesion. Immunolabeling for both p16 and MTAP protein expression provides a tool to evaluate tissues with intact morphology for p16 gene homozygous deletions. The concordant loss of expression of both genes in PanIN lesions demonstrates that homozygous deletions of the p16 tumor suppressor gene can occur in noninvasive precursor lesions.",
keywords = "Homozygous deletion, MTAP, p16, Pancreatic intraepithelial neoplasia, Precursor lesion",
author = "Hustinx, {Steven R.} and Leoni, {Lorenzo M.} and Yeo, {Charles J.} and Brown, {Priscilla N.} and Goggins, {Michael S} and Kern, {Scott E} and Hruban, {Ralph H} and Anirban Maitra",
year = "2005",
month = "7",
doi = "10.1038/modpathol.3800377",
language = "English (US)",
volume = "18",
pages = "959--963",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia

T2 - Evidence of homozygous deletion in a noninvasive precursor lesion

AU - Hustinx, Steven R.

AU - Leoni, Lorenzo M.

AU - Yeo, Charles J.

AU - Brown, Priscilla N.

AU - Goggins, Michael S

AU - Kern, Scott E

AU - Hruban, Ralph H

AU - Maitra, Anirban

PY - 2005/7

Y1 - 2005/7

N2 - The p16INK4A/CDKN2A (p16) gene on chromosome 9p21 is inactivated in >90% of invasive pancreatic cancers. In 40% of pancreatic cancers the p16 gene is inactivated by homozygous deletion, in 40% by an intragenic mutation coupled with loss of the second allele, and in 10-15% by hypermethylation of the p16 gene promoter. Immunohistochemical labeling for the p16 gene product parallels gene status, but does not provide information of the mechanism of p16 gene inactivation. The methylthioadenosine phosphorylase gene (MTAP) gene also resides on chromosome 9p21, approximately 100kb telomeric to the p16 gene. The MTAP gene is frequently contained within p16 homozygous deletions, producing concordant loss of both p16 and MTAP gene expression. Concordant loss of both p16 and MTAP protein expression can therefore be used as a surrogate marker for p16 homozygous deletion. Here we immunolabeled a series of pancreatic intraepithelial neoplasia (PanIN) lesions of various histologic grades for the p16 and MTAP gene products using a high-throughput PanIN tissue microarray (TMA) format. We demonstrate concordant loss of p16 and MTAP protein expression in 6/73 (8%) PanINs, including five high-grade lesions and one low-grade lesion. Immunolabeling for both p16 and MTAP protein expression provides a tool to evaluate tissues with intact morphology for p16 gene homozygous deletions. The concordant loss of expression of both genes in PanIN lesions demonstrates that homozygous deletions of the p16 tumor suppressor gene can occur in noninvasive precursor lesions.

AB - The p16INK4A/CDKN2A (p16) gene on chromosome 9p21 is inactivated in >90% of invasive pancreatic cancers. In 40% of pancreatic cancers the p16 gene is inactivated by homozygous deletion, in 40% by an intragenic mutation coupled with loss of the second allele, and in 10-15% by hypermethylation of the p16 gene promoter. Immunohistochemical labeling for the p16 gene product parallels gene status, but does not provide information of the mechanism of p16 gene inactivation. The methylthioadenosine phosphorylase gene (MTAP) gene also resides on chromosome 9p21, approximately 100kb telomeric to the p16 gene. The MTAP gene is frequently contained within p16 homozygous deletions, producing concordant loss of both p16 and MTAP gene expression. Concordant loss of both p16 and MTAP protein expression can therefore be used as a surrogate marker for p16 homozygous deletion. Here we immunolabeled a series of pancreatic intraepithelial neoplasia (PanIN) lesions of various histologic grades for the p16 and MTAP gene products using a high-throughput PanIN tissue microarray (TMA) format. We demonstrate concordant loss of p16 and MTAP protein expression in 6/73 (8%) PanINs, including five high-grade lesions and one low-grade lesion. Immunolabeling for both p16 and MTAP protein expression provides a tool to evaluate tissues with intact morphology for p16 gene homozygous deletions. The concordant loss of expression of both genes in PanIN lesions demonstrates that homozygous deletions of the p16 tumor suppressor gene can occur in noninvasive precursor lesions.

KW - Homozygous deletion

KW - MTAP

KW - p16

KW - Pancreatic intraepithelial neoplasia

KW - Precursor lesion

UR - http://www.scopus.com/inward/record.url?scp=23044485887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044485887&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800377

DO - 10.1038/modpathol.3800377

M3 - Article

C2 - 15832197

AN - SCOPUS:23044485887

VL - 18

SP - 959

EP - 963

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 7

ER -